Our founder team- DNA Damage Repair and Cancer Therapy Leading Innovation Team - was awarded as the 2020 Hangzhou Leading Innovation and Entrepreneurship Team.

        Led by Prof. Yu Xiaochun, founder of SynRx Therapeutics and Professor of the School of Life Sciences at Westlake University, the team's research results greatly impacted the treatment of advanced cancer.

        Meanwhile, the new R&D group will push for the smooth implementation of SynRx's new drug projects.